Please assess the completion status of the following clinical trial:

Trial Title: Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* hypertension~* angina pectoris CCS class II-IV~* objective signs of ischemia on exercise-ECG or myocardial SPECT~* no significant stenosis on angiography (minimal lumen diameter \>50% of relevant reference segment)~Exclusion Criteria:~* known allergy to any study medication~* abnormal lab tests of clinical significance~* valvular disease of haemodynamic significance~* known secondary hypertension~* atrial fibrillation or other significant arrythmias~* myocardial infarction \< 30 days before inclusion~* resting angina \< one week before inclusion~* known endocrine disease, nephropathy or hepatic disease~* present malignant disease~* pregnancy~* fertile women not using safe contraceptives \> 6 months before inclusion. Use of contraceptives must continue 1 month after completion or retraction from the study~* body mass index \> 30~* significant chronic obstructive lung disease (FEV1 \< 1.5 l)~* participant in another study including test medicine~* present treatment with dipyridamole~* present treatment with phosphodiesterase-5-inhibitors that the patient does not want to discontinue during the study period~* heart transplanted patients~* patients with magnetizable metallic implants

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Vasodilatory (Type: EXPERIMENTAL): Patients in this arm will receive intensive vasodilatory treatment to lower blood pressure

Based on this trial design, predict the completion outcome and termination type (if applicable).